Deuis, J.R.; Wingerd, J.S.; Winter, Z.; Durek, T.; Dekan, Z.; Sousa, S.R.; Zimmermann, K.; Hoffmann, T.; Weidner, C.; Nassar, M.A.;
et al. Analgesic Effects of GpTx-1, PF-04856264 and CNV1014802 in a Mouse Model of NaV1.7-Mediated Pain. Toxins 2016, 8, 78.
https://doi.org/10.3390/toxins8030078
AMA Style
Deuis JR, Wingerd JS, Winter Z, Durek T, Dekan Z, Sousa SR, Zimmermann K, Hoffmann T, Weidner C, Nassar MA,
et al. Analgesic Effects of GpTx-1, PF-04856264 and CNV1014802 in a Mouse Model of NaV1.7-Mediated Pain. Toxins. 2016; 8(3):78.
https://doi.org/10.3390/toxins8030078
Chicago/Turabian Style
Deuis, Jennifer R., Joshua S. Wingerd, Zoltan Winter, Thomas Durek, Zoltan Dekan, Silmara R. Sousa, Katharina Zimmermann, Tali Hoffmann, Christian Weidner, Mohammed A. Nassar,
and et al. 2016. "Analgesic Effects of GpTx-1, PF-04856264 and CNV1014802 in a Mouse Model of NaV1.7-Mediated Pain" Toxins 8, no. 3: 78.
https://doi.org/10.3390/toxins8030078
APA Style
Deuis, J. R., Wingerd, J. S., Winter, Z., Durek, T., Dekan, Z., Sousa, S. R., Zimmermann, K., Hoffmann, T., Weidner, C., Nassar, M. A., Alewood, P. F., Lewis, R. J., & Vetter, I.
(2016). Analgesic Effects of GpTx-1, PF-04856264 and CNV1014802 in a Mouse Model of NaV1.7-Mediated Pain. Toxins, 8(3), 78.
https://doi.org/10.3390/toxins8030078